Fundraising FoxSea Pharmaceuticals
Cambridge, US · Founded 2013 · Iowa LLC · 1 known investors
Find your way into Sea Pharmaceuticals
Sign up to see every warm intro you have to Sea Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sea Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Sea Pharmaceuticals was founded in 2013 by Benjamin Cravatt.
BC
Benjamin CravattManager
JP
James P. PearsonPRESIDENT, CHIEF EXECUTIVE OFFICER, CHIEF SCIENCE OFFICER
EJ
Eduardo J. MartinezVice President
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.9M disclosed across 4 of 5 rounds · 2016–2025
▶$71.1KraisedMay 2026 · 7 investors · PharmaceuticalsRule 506(b)
▶$71.1KraisedMay 2026 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mark G. CurrieDirector
- Shaker SadasivamDirector
- James P. PearsonExecutive Officer, Director
- Nabil ElkouhDirector
- Michael J. HigginsDirector
- Walter Kendall BrownDirector
- Eric R OlsonDirector
- Offering amount
- $1.7M
- Amount sold
- $71.1K
- Minimum investment
- $7.5K
- Proceeds to insiders
- $150K
- First sale
- Jul 2025
- Incorporated
- Limited Liability Company, Iowa
- Federal exemptions
- 06b
▶$417.4KraisedFeb 2025 · 16 investors · PharmaceuticalsRule 506(b)
▶$417.4KraisedFeb 2025 · 16 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- NABIL J. ELKOUHDirector
- ERIC R OLSONDirector
- MICHAEL F. HIGGINSDirector
- SHAKER SADASIVAMDirector
- MARK G. CURRIEDirector
- JAMES P PEARSONExecutive Officer, Director
- WALTER KENDALL BROWNDirector
- Offering amount
- $2.2M
- Amount sold
- $417.4K
- Minimum investment
- $7.5K
- Proceeds to insiders
- $150K
- First sale
- Dec 2023
- Incorporated
- Limited Liability Company, Iowa
- Federal exemptions
- 06b
▶$1.5MraisedJan 2023 · 27 investors · PharmaceuticalsRule 506(b)
▶$1.5MraisedJan 2023 · 27 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin F. CravattDirector
- Eric R. OlsonDirector
- Michael HigginsDirector
- Nabil ElkouhDirector
- Mark G. CurrieDirector
- Shaker SadasivamDirector
- James P. PearsonExecutive Officer, Director
- Walter Kendall BrownDirector
- Offering amount
- $2M
- Amount sold
- $1.5M
- Minimum investment
- $6.5K
- Proceeds to insiders
- $150K
- First sale
- Mar 2019
- Incorporated
- Limited Liability Company, Iowa
- Federal exemptions
- 06b
▶$2MofferedNov 2017 · PharmaceuticalsRule 506(b)
▶$2MofferedNov 2017 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Nabil ElkouhDirector
- Eric R. OlsonDirector
- James P. PearsonExecutive Officer, Director
- W. Kendall BrownDirector
- Shaker SadasivamDirector
- Anne M. SullivanExecutive Officer
- Benjamin F. CravattDirector
- Michael J. HigginsDirector
- Eduardo J. MartinezExecutive Officer
- Offering amount
- $2M
- Minimum investment
- $5K
- Incorporated
- Limited Liability Company, Iowa, 2013
- Federal exemptions
- 06b
▶$887KraisedNov 2016 · 38 investors · PharmaceuticalsRule 506(b)
▶$887KraisedNov 2016 · 38 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- James P. PearsonExecutive Officer, Director
- Michael HigginsDirector
- Eric OlsonDirector
- Nabil ElkouhDirector
- Shaker SadasivamDirector
- W. Kendall BrownDirector
- Benjamin CravattDirector
- Eduardo J. MartinezExecutive Officer
- Offering amount
- $3.5M
- Amount sold
- $887K
- Minimum investment
- $5K
- First sale
- Feb 2016
- Incorporated
- Limited Liability Company, Iowa, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Sea Pharmaceuticals?
- Sea Pharmaceuticals was founded by Benjamin Cravatt in 2013.
- Who are Sea Pharmaceuticals's investors?
- Sea Pharmaceuticals's investors include Iaso Ventures.
- How much funding has Sea Pharmaceuticals raised?
- Sea Pharmaceuticals has disclosed $2.9M raised across 4 of its 5 known rounds.
- Where is Sea Pharmaceuticals headquartered?
- Sea Pharmaceuticals is headquartered in Cambridge, US.